Curbside Consultation in GI Cancer for the Gastroenterologist: 49 Clinical Questions

Was: $98.95
Now: $49.48
Author(s):
Douglas Adler, MD
ISBN 10:
1556429843
ISBN 13:
9781556429842
Pages:
288
Cover:
Trade Paperback
Publication Date:
2011
Item Number:
79842
Product Dimensions:
7.00 x 10.00 x 0.50 inches

Book Description

Are you looking for concise, practical answers to questions that are often left unanswered by traditional cancer references that are not designed for gastroenterologists? Are you seeking brief, evidence-based advice for complicated cases or patients with complications that need management? Curbside Consultation in GI Cancer for the Gastroenterologist: 49 Clinical Questions provides quick and direct answers to the thorny questions commonly posed during a “curbside consultation” between colleagues.

Dr. Douglas G. Adler has designed this unique reference, which offers expert advice, preferences, and opinions on tough clinical questions commonly associated with GI cancer. The unique Q&A format provides quick access to current information related to GI cancer with the simplicity of a conversation between two colleagues. Numerous images, diagrams, and references are included to enhance the text and to illustrate the treatment of GI cancer patients.

Curbside Consultation in GI Cancer for the Gastroenterologist: 49 Clinical Questions provides information basic enough for residents while also incorporating expert advice that even high-volume clinicians will appreciate. Gastroenterologists, fellows and residents in training, surgical attendings, and surgical residents will benefit from the user-friendly and casual format and the expert advice contained within.

Some of the questions that are answered:
• An 81-year-old man is found to have unresectable esophageal cancer and malignant dysphagia. Should he have a stent? A nasogastric feeding tube? A PEG tube?
• How is tumor-related bleeding from gastric cancers best approached?
• Do patients with pancreatic cancer and jaundice need to have an ERCP preoperatively?
• What is the role of ERCP and EUS in patients with suspected cholangiocarcinoma?
• Why are rectal cancers so different from colon cancers with regards to medical and surgical management?

Curbside Consultation in GI Cancer for the Gastroenterologist: 49 Clinical Questions illustrates how patients at different points in their treatment may go back and forth between specialists to receive coordination of care, and incorporates input from gastroenterologists, surgeons, radiologists, and oncologists. While providing up-to-date information, this book will help gastroenterologists to manage complex cancer-related issues and guide physicians through the maze of cancer-related treatments available.

Ideal for practicing gastroenterologists, gastroenterology fellows, surgeons, oncologists, residents, and medical students, Curbside Consultation in GI Cancer for the Gastroenterologist: 49 Clinical Questions is sure to benefit anyone caring for patients with gastrointestinal cancers.
 

More Information

Douglas G. Adler, MD, FACG, AGAF, FASGE received his medical degree from Cornell University Medical College. He completed his residency in internal medicine at Beth Israel Deaconess Medical Center/Harvard Medical School. Dr. Adler completed both a general GI fellowship and a therapeutic endoscopy/ERCP fellowship at Mayo Clinic in Rochester, Minnesota. He then returned to the Beth Israel Deaconess Medical Center for a fellowship in endoscopic ultrasound (EUS).  

Dr. Adler is currently an Associate Professor of Medicine and Director of Therapeutic Endoscopy at the University of Utah School of Medicine in Salt Lake City, Utah. Working mostly out of the School of Medicine’s Huntsman Cancer Institute, Dr. Adler’s clinical, educational, and research efforts focus on the diagnosis and management of patients with gastrointestinal cancers, with an emphasis on therapeutic endoscopy. He is the author of more than 150 scientific publications and book chapters.

 

Dedication                                                                                                                                          
Acknowledgments                                                                                                                              
About the Editor                                                                                                                     
Contributing Authors                                                                                                                        
Preface                                                                                                                                               
 
Section I         Esophagus                                                                                                     
 
Question 1       What Are the Risk Factors for the Development of Esophageal Cancer?                
Kevin D. Halsey, MD and Bruce D. Greenwald, MD
 
Question 2       Do All Patients With Esophageal Cancer Require Surgery or Can
Some Be Managed With Nonsurgical (Endoscopic, Oncologic, Etc)
Methods Alone?                                                                                                        
Robin B. Mendelsohn, MD and Christopher J. DiMaio, MD
 
Question 3       What Options Exist for Enteral Feeding in Preoperative Patients
With Esophageal Cancer Who Have Dysphagia?                                                      
                        Vivek Kaul, MD, FACG
 
Question 4       An 81-Year-Old Man Is Found to Have Unresectable Esophageal
Cancer and Malignant Dysphagia. Should He Have a Stent? A Nasogastric
Feeding Tube? A Percutaneous Endoscopic Gastrostomy Tube?                             
                        Katarina B. Greer, MD, MS and Ashley L. Faulx, MD, FASGE
 
Question 5       How Should Malignant Tracheoesophageal Fistulae Be Managed
in Patients With Esophageal Cancer?                                                                        
Ananya Das, MD, FACG, FASGE
 
Question 6       A 55-Year-Old Man Undergoes an Esophagectomy for Esophageal
Cancer. Two Years Later, He Develops Dysphagia and a Contrast
Study Discloses a Narrowing at His Anastomosis. How Should This Be
Investigated and Treated?                                                                                         
                        Michael Walker, MD and John Fang, MD
 
Section II        Gastric                                                                                                                       
 
Question 7       What Are The Known Risk Factors For the Development of Gastric Cancer?        
                        Selvi Thirumurthi, MD, MS
 
Question 8       What Is the Relationship Between Helicobacter pylori and the
Development of Gastric Cancer and Lymphoma? Do All Patients With
Helicobacter pylori-Related Gastric Malignancies Need Surgery?                           
                        Scott Pollack, MD and Virendra Joshi, MD, AGAF
 
Question 9       What Options Exist for Patients With Gastric Outlet Obstruction
From Gastric Cancer?                                                                                                
                        Andrew Singleton, MD and Robert E. Glasgow, MD
 
Question 10     What Is the Role of Endoscopic Ultrasound in Staging Gastric Cancers?               
                        Jeffrey L. Tokar, MD
 
Question 11     How Is Tumor-Related Bleeding From Gastric Cancers Best Approached?            
                        Jeffrey L. Tokar, MD
 
Question 12     What Is Linitis Plastica and How Does Its Development Affect
the Management and Prognosis of Patients With Gastric Cancer?                           
                        Caroline R. Tadros, MD
 
Question 13     A 42-Year-Old Woman Has an Esophagogastroduodenoscopy for Dyspepsia.
A 2-cm Submucosal Lesion in the Proximal Stomach Is Seen. How Should This
Lesion Be Further Evaluated and Treated?                                                               
                        Robert C. Wrona, MD and Robert E. Glasgow, MD
 
Section III      Pancreatic                                                                                                                 
 
Question 14     A 54-Year-Old Woman Has Weight Loss and Back Pain. An Ultrasound
Is Suggestive of a Solid Mass in Her Pancreas. How Should Her
Evaluation Best Proceed With Regards to Diagnosis and Staging?                        
                        Randall K. Pearson, MD
 
Question 15     Do Patients With Pancreatic Cancer and Jaundice Need to Have an
Endoscopic Retrograde Cholangiopancreatography Preoperatively?                        
                        Todd H. Baron, MD
 
Question 16     A 43-Year-Old Woman Has Syncope Due to Hypoglycemia. An
Insulinoma Is Suspected. Computed Tomography and Magnetic Resonance
Imaging of Her Abdomen Are Negative. How Should This Patient Be
Further Evaluated?                                                                                                    
                        Sergey V. Kantsevoy, MD, PhD
 
Question 17     How Should a Cystic Pancreatic Lesion Be Evaluated Prior to Treatment?
Which Cystic Lesions in the Pancreas Require Resection and Which
Can Be Followed Conservatively?                                                                
                        Randall K. Pearson, MD
 
Question 18     What Is the Role of Metal Biliary Stents in Patients With Unresectable
Pancreatic Cancer and Jaundice?                                                                               
                        Sergey V. Kantsevoy, MD, PhD
 
Question 19     Should Patients With a Strong Family History of Pancreatic Cancer
Be Screened for the Disease, and if so, How?                                                          
                        David Chu, MD and Douglas G. Adler, MD, FACG, AGAF, FASGE
 
Question 20     A 78-Year-Old Woman With Pancreatic Cancer and Severe Pain Is
Referred to You for Evaluation. What Is the Role of Celiac Plexus Neurolysis
to Control Pain in These Patients?                                                                             
                        Nikhil Banerjee, MD and Douglas G. Adler, MD, FACG, AGAF, FASGE
 
Question 21     A 70-Year-Old Man With Pancreatic and Liver Cancers Develops Gastric
Outlet Obstruction Due to a Mass Compressing the Mass Proximal Duodenum.
What Treatment Options Exist for This Situation?                                                   
                        Todd H. Baron, MD
 
Question 22     A 67-Year-Old Man With Pancreatic Adenocarcinoma Undergoes Endoscopic
Ultrasound, Which Reveals Malignant Adenopathy and Superior Mesenteric
and Portal Vein Involvement. What Treatment Options Exist for This Patient?      
                        Sean J. Mulvihill, MD
 
Question 23     A 68-Year-Old Man Develops Painless Jaundice. Endoscopic Retrograde Cholangiopancreatography Demonstrates a Large Ampullary Mass. Biopsies
Demonstrate Adenocarcinoma. How Should This Patient Be Managed?                 
                        Shyam J. Thakkar, MD and Douglas Pleskow, MD, AGAF, FASGE
 
Section IV      Biliary                                                                                                                        
 
Question 24     A 24-Year-Old Female Is Found to Have Primary Sclerosing Cholangitis.
What Is Her Risk of Developing Cholangiocarcinoma?                                            
                        James D. Morris, MD and Virendra Joshi, MD, AGAF
 
Question 25     What Is the Role of Endoscopic Retrograde Cholangiopancreatography and
Endoscopic Ultrasound in Patients With Suspected Cholangiocarcinoma?              
                        Rabi Kundu, MD, FRCS and Douglas Pleskow, MD, AGAF, FASGE
 
Question 26     Which Patients With Cholangiocarcinoma Are Candidates For Surgical
Resection? Is Liver Transplant an Option for Patients With Cholangiocarcinoma? 
                        William R. Hutson, MD
 
Question 27     What Oncologic Treatment Options Exist for Patients With Cholangiocarcinoma
Who Are Not Considered Surgical Candidates?                                                       
                        Kimberly Jones, MD
 
Question 28     Should Patients With Unresectable Cholangiocarcinoma and Jaundice
Be Managed Via Endoscopy With Stents, Interventional Radiologists
With Drains, or Both?                                                                                                
                        Allene Salcedo Burdette, MD
 
Question 29     What Is the Role of Photodynamic Therapy and Brachytherapy in
Patients With Cholangiocarcinoma?                                                                          
                        Ananya Das, MD, FACG, FASGE
 
Section V        Hepatic                                                                                                                      
 
Question 30     What Are the Risk Factors for the Development of Heptaocellular Cancer?                       
                        Ravinder R. Kurella, MD and William M. Tierney, MD
 
Question 31     A 55-Year-Old Man is Newly Diagnosed With Cirrhosis From Hepatitis C.
What Is the Best Imaging Modality and Treatment Strategy to Screen Him for
Hepatocellular Carcinoma?                                                                                        
                        William R. Hutson, MD
 
Question 32     Which Patients With Hepatocellular Cancer Are Candidates for Liver
Transplantation or Surgical Resection?                                                                      
                        Colin T. Swales, MD and Fredric D. Gordon, MD
 
Question 33     In Nonsurgical Patients With Hepatocellular Cancer, What Treatment Options
Exist, and How Effective Are They?                                                                        
                        Allene Salcedo Burdette, MD
 
Question 34     A 67-Year-Old Female With Cirrhosis Develops Hepatocellular Cancer.
Shortly After Diagnosis, She Becomes Jaundiced. How Do You Determine if
the Jaundice Is Due to Cirrhosis, Biliary Obstruction, or Both?                               
                        Darryn Potosky, MD and Eric Goldberg, MD
 
Question 35     A 55-Year-Old Cirrhotic Man Is Found to Have a 1.5-cm Liver Lesion and
an Elevated Alpha-Fetoprotein. Is a Biopsy or Other Testing Required to Confirm
a Diagnosis of Hepatocellular Carcinoma? What Other Evaluation Is Warranted?
                        Fredric D. Gordon, MD
 
Section VI      Small Bowel and Colon                                                                                           
 
Question 36     What Diseases Increase the Risk of Developing Small Bowel Carcinoma?              
                        Caroline R. Tadros, MD
 
Question 37     What Are the Current Guidelines for Screening for Colorectal Cancer?      
                        Harshinie C. Amaratunge, MD and Waqar A. Qureshi, MD
 
Chapter 38      What Are the Risk Factors for Colorectal Cancer?                                                   
                        Devina Bhasin, MD and Ashley L. Faulx, MD, FASGE
 
Chapter 39      What Surgical Options Are Available for Patients With Colon Cancer, Including
Those Who Present With Acute Obstruction?                                                           
                        Clifford S. Cho, MD, FACS
 
Chapter 40      How Should Patients With a Solitary Liver Metastasis From Colon
Cancer Be Evaluated and Treated?                                                                           
                        Clifford S. Cho, MD, FACS
 
Chapter 41      What Patients With Colorectal Cancer Should Be Considered for a
Colonic Stent?                                                                                                                       
                        Jeffrey Laczek, MD and Peter Darwin, MD
 
Chapter 42      What Is the Best Surveillance Regimen for Patients Following Colon
Cancer Resection?                                                                                         
                        David Chu, MD and Douglas G. Adler, MD, FACG, AGAF, FASGE
 
Chapter 43      A 78-Year-Old Man With Metastatic Colon Cancer Had a Colonic
Stent Placed 16 Months Ago. He Has Developed Recurrent Obstruction at the
Site of the Tumor. How Should This Patient Be Evaluated and Managed? 
                        Waqar A. Qureshi, MD and Yasser H. Shaib, MD, MPH, FASGE
 
Section VII     Rectum and Anus    
 
Question 44     A 55-Year-Old Man Presents With Rectal Bleeding. A Digital Rectal
Exam Reveals a Firm 1-cm Perianal Lesion. Biopsy of This Lesion Is Consistent
With Squamous Cell Carcinoma. How Do You Manage This Patient?
                        Selvi Thirumurthi, MD, MS
 
Question 45     Why Are Rectal Cancers so Different From Colon Cancers With Regard
to Medical and Surgical Management?
                        Kimberly Jones, MD
 
Question 46     What Is the Role of Endorectal Ultrasound in Patients With Rectal
Cancer? Do All Patients With Rectal Cancer Need to Have an Endorectal
Ultrasound?
                        Leyla J. Ghazi, MD and David A. Schwartz, MD
 
Question 47     Which Patients With Rectal Cancer Should Undergo Neoadjuvant Therapy
and Which Patients Can Proceed Directly to Surgery?
                        Ryan C. Van Woerkom, MD and Douglas G. Adler, MD, FACG, AGAF, FASGE
 
Question 48     How Should Patients Be Followed After Successful Treatment for
Rectal Cancer?
                        Brad Shepherd, MD; David A. Schwartz, MD; and Paul E. Wise, MD
 
Question 49     How Low in the Rectum Can a Colonic Stent Be Safely Placed? What
Happens if the Stent Is Deployed Too Far Distally?
                        Vivek Kaul, MD, FACG
 
Financial Disclosures
Index